Nervgen Pharma (NGEN) Divestments (2025 - 2026)
Nervgen Pharma (NGEN) posted quarterly Divestments of $6133.3 for Q1 2026, down 65.12% year-over-year from $17584.6 in Q1 2025, and down 65.12% quarter-over-quarter from $17584.6 in Q1 2025.
Nervgen Pharma (NGEN) Divestments (2025 - 2026) Analysis & Trends
Nervgen Pharma (NGEN) has reported Divestments for 2 consecutive years, with $6133.3 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -13.21 Mn |
| 10 | Nervgen Pharma | 164.09 Mn | 164.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,133.35 |
| Mar 31, 2025 | 17,584.60 |